Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Azad

Showing results (251-260 of 353) with videos related to

Pageof 36
Sort By:
European Urology Focus|August 3, 2020
Prognostic Impact of Total Plasma Cell-free DNA Concentration in Androgen Receptor Pathway Inhibitor-treated Metastatic Castration-resistant Prostate CancerHeidi Fettke, Edmond M Kwan, Patricia Bukczynska, et al.
The Prostate|September 2, 2014
A retrospective, Canadian multi-center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration-resistant prostate cancerArun A Azad, Raya Leibowitz-Amit, Bernhard J Eigl, et al.
Brazilian Journal of Biology = Revista Brasleira De Biologia|June 8, 2022
Antibiotic resistance pattern and pathological features of avian pathogenic Escherichia coli O78:K80 in chickensS Usman, A Anjum, M Usman, et al.
JCO Clinical Cancer Informatics|July 25, 2023
Multi-Omic Integration of Blood-Based Tumor-Associated Genomic and Lipidomic Profiles Using Machine Learning Models in Metastatic Prostate CancerShikai Fang, Shandian Zhe, Hui-Ming Lin, et al.
Prostate Cancer and Prostatic Diseases|May 5, 2023
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancerTahlia Scheinberg, Hui-Ming Lin, Michael Fitzpatrick, et al.
Therapeutic Advances in Medical Oncology|June 16, 2023
Safety of Lutetium-177 prostate-specific membrane antigen-617 (PSMA-617) radioligand therapy in the setting of severe renal impairment: a case report and literature reviewDuncan E K Sutherland, Raghava Kashyap, Price Jackson, et al.
International Journal of Molecular Sciences|April 27, 2024
<i>APOE</i> ε2-Carriers Are Associated with an Increased Risk of Primary Angle-Closure Glaucoma in Patients of Saudi OriginAltaf A Kondkar, Taif A Azad, Tahira Sultan, et al.
Oncogene|October 6, 2015
PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancerS-J Fan, C Snell, H Turley, et al.
ESMO Real World Data and Digital Oncology|February 27, 2026
Registry-based randomised phase II study of Enzalutamide versus Abiraterone: assessing cognitive function in eLderly patients with metastatic castration-resistant Prostate cancer (REAL-Pro)A Anton, C Steer, M Arasaratnam, et al.
Biotechniques|July 14, 2020
Analytical validation of an error-corrected ultra-sensitive ctDNA next-generation sequencing assayHeidi Fettke, Jason A Steen, Edmond M Kwan, et al.
Pageof 36

Showing results (251-260 of 353) with videos related to

Sort By:
Pageof 36
European Urology Focus|August 3, 2020
Prognostic Impact of Total Plasma Cell-free DNA Concentration in Androgen Receptor Pathway Inhibitor-treated Metastatic Castration-resistant Prostate CancerHeidi Fettke, Edmond M Kwan, Patricia Bukczynska, et al.
The Prostate|September 2, 2014
A retrospective, Canadian multi-center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration-resistant prostate cancerArun A Azad, Raya Leibowitz-Amit, Bernhard J Eigl, et al.
Brazilian Journal of Biology = Revista Brasleira De Biologia|June 8, 2022
Antibiotic resistance pattern and pathological features of avian pathogenic Escherichia coli O78:K80 in chickensS Usman, A Anjum, M Usman, et al.
JCO Clinical Cancer Informatics|July 25, 2023
Multi-Omic Integration of Blood-Based Tumor-Associated Genomic and Lipidomic Profiles Using Machine Learning Models in Metastatic Prostate CancerShikai Fang, Shandian Zhe, Hui-Ming Lin, et al.
Prostate Cancer and Prostatic Diseases|May 5, 2023
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancerTahlia Scheinberg, Hui-Ming Lin, Michael Fitzpatrick, et al.
Therapeutic Advances in Medical Oncology|June 16, 2023
Safety of Lutetium-177 prostate-specific membrane antigen-617 (PSMA-617) radioligand therapy in the setting of severe renal impairment: a case report and literature reviewDuncan E K Sutherland, Raghava Kashyap, Price Jackson, et al.
International Journal of Molecular Sciences|April 27, 2024
<i>APOE</i> ε2-Carriers Are Associated with an Increased Risk of Primary Angle-Closure Glaucoma in Patients of Saudi OriginAltaf A Kondkar, Taif A Azad, Tahira Sultan, et al.
Oncogene|October 6, 2015
PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancerS-J Fan, C Snell, H Turley, et al.
ESMO Real World Data and Digital Oncology|February 27, 2026
Registry-based randomised phase II study of Enzalutamide versus Abiraterone: assessing cognitive function in eLderly patients with metastatic castration-resistant Prostate cancer (REAL-Pro)A Anton, C Steer, M Arasaratnam, et al.
Biotechniques|July 14, 2020
Analytical validation of an error-corrected ultra-sensitive ctDNA next-generation sequencing assayHeidi Fettke, Jason A Steen, Edmond M Kwan, et al.
Pageof 36